![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 39/395 | (2006.01) |
G01N 33/567 | (2006.01) | ||
C07K 16/24 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 39/00 | (2006.01) | ||
A61K 47/18 | (2017.01) |
(11) | Number of the document | 3219328 |
(13) | Kind of document | T |
(96) | European patent application number | 17156111.1 |
Date of filing the European patent application | 2006-12-28 | |
(97) | Date of publication of the European application | 2017-09-20 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
(46) | Date of publication of the claims translation | 2020-09-10 |
(30) | Number | Date | Country code |
754889 P | 2005-12-29 | US |
(72) |
BENSON, Jacqueline, US
CARTON, Jill, US
CUNNINGHAM, Mark, US
ORLOVSKY, Yevgeniya I., US
RAUCHENBERGER, Robert, DE
SWEET, Raymond, US
|
(73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Žmogaus anti-IL-23 antikūnai, kompozicijos, būdai ir panaudojimai |
HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHOD AND USES |
Payment date | Validity (years) | Amount | |
2021-11-24 | 16 | 347.00 EUR |